The DOI matches its Crossref record; 481 of the 481 references it cites were found in a registry or an index.
Loss of Tumor Suppressor Gene Function in Human Cancer: An Overview
Open accessAbstract
Cancer is a disease caused by the accumulation of genetic and epigenetic changes in two types of genes: tumor suppressor genes (TSGs) and proto-oncogenes. Extensive research has been conducted over the last few decades to elucidate the role of TSGs in cancer development. In cancer, loss of TSG function occurs via the deletion or inactivation of two alleles, according to Knudson’s two-hit model hypothesis. It has become clear that mutations in TSGs are recessive at the level of an individual cell; therefore, a single mutation in a TSG is not sufficient to cause carcinogenesis. However, many studies have identified candidate TSGs that do not conform with this standard definition, including genes inactivated by epigenetic silencing rather than by deletion. In addition, proteasomal degradation by ubiquitination, abnormal cellular localization, and transcriptional regulation are also involved in the inactivation of TSGs. This review incorporates these novel additional mechanisms of TSG inactivation into the existing two-hit model and proposes a revised multiple-hit model that will enable the identification of novel TSGs that can be used as prognostic and predictive biomarkers of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 401–481 of 481
Analysis of the TGF β functional pathway in epithelial ovarian carcinoma
Francis-Thickpenny, K. M., Richardson, D., van Ee, C. C., Love, D. R., Winship, I., Baguley, B. C., Chenevix‐Trench, G., & Shelling, A. N. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1950 · Cited by 28
Loss of LKB1 in high‐grade endometrial carcinoma: LKB1 is a novel transcriptional target of p53
Co, N. N., Iglesias, D. A., Celestino, J., Kwan, S., Mok, S. C., Schmandt, R. E., & Lu, K. H. (2014) · Cancer · doi:10.1002/cncr.28854 · Cited by 27
Yimit, A., Mitomi, H., Nakai, K., Himuro, T., Saito, T., Takahashi, M., Arakawa, A., Yao, T., & Saito, M. (2013) · Histopathology · doi:10.1111/his.12220 · Cited by 27
BRCA1 germline mutation and glioblastoma development: report of cases
Boukerroucha, M., Josse, C., Segers, K., ElGuendi, S., Frères, P., Jérusalem, G., & Bours, V. (2015) · BMC Cancer · doi:10.1186/s12885-015-1205-1 · Cited by 27
Yano, M., Asahara, T., Dohi, K., Mizuno, T., Iwamoto, K. S., & Seyama, T. (1999) · International Journal of Oncology · doi:10.3892/ijo.14.3.447 · Cited by 27
Aberrations of the p14ARF and p16INK4a Genes in Renal Cell Carcinomas
Kawada, Y., Nakamura, M., Ishida, E., Shimada, K., Oosterwijk, E., Uemura, H., Hirao, Y., Chul, K. S., & Konishi, N. (2001) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2001.tb02152.x · Cited by 27
Xie, W. Q., Aisner, S. C., Baredes, S., Sreepada, G. S., Shah, R. P., & Reiß, M. (2012) · Head & Neck · doi:10.1002/hed.22924 · Cited by 27
Saegusa, M., Machida, D., & Okayasu, I. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.0966 · Cited by 26
Ling, Y., Huang, G., Fan, L., Wei, L., Zhu, J., Liu, Y., Zhu, C., & Zhang, C. (2010) · Journal of Clinical Pathology · doi:10.1136/jcp.2010.082875 · Cited by 26
Grüttgen, A., Reichenzeller, M., Jünger, M., Schlien, S., Affolter, A., & Bosch, F. X. (2001) · The Journal of Pathology · doi:10.1002/path.906 · Cited by 26
Mutational analysis of the PTEN/MMAC1 gene in primary oesophageal squamous cell carcinomas.
Hu, Y. C., Lam, A. K.-Y., Tang, J. C. O., & Srivastava, G. (1999) · Molecular Pathology · doi:10.1136/mp.52.6.353 · Cited by 26
Changes in retinoblastoma gene expression during cervical cancer progression
Salcedo, M., Taja‐Chayeb, L., Utrera‐Barillas, D., Chávez, P., Hidalgo‐Miranda, A., Pérez‐Plasencia, C., Benítez, L. G., Castañeda, C., Delgado, R., & Gariglio, P. (2002) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.2002.00198.x · Cited by 25
Chen, P.-Y., Yen, J.-H., Kao, R. H., & Chen, J. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071282 · Cited by 25
Kassem, H. S., Varley, J. M., Hamam, S., & Margison, G. P. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1595 · Cited by 25
Inactivation of p16 by CpG hypermethylation in renal cell carcinoma
Vidaurreta, M., Maestro, M. L., Casla, M. T. S., Maestro, C., Rafael, S., Veganzones, S., Moreno, J., Blanco, J., Silmi, Á., & Arroyo, M. (2007) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.01.018 · Cited by 25
MDM2-Mediated Degradation of p14ARF: A Novel Mechanism to Control ARF Levels in Cancer Cells
Vivo, M., Matarese, M., Sepe, M., Martino, R. D., Festa, L., Calabrò, V., Mantia, G. L., & Pollice, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117252 · Cited by 25
Geradts, J., Wilentz, R. E., & Roberts, H. (2001) · Modern Pathology · doi:10.1038/modpathol.3880452 · Cited by 25
Bian, C., Li, Z., Xu, Y., Wang, J., Xu, L., & Shen, H. (2015) · World Journal of Surgical Oncology · doi:10.1186/s12957-015-0502-0 · Cited by 25
Tsujimoto, H., Hagiwara, A., Sugihara, H., Hattori, T., & Yamagishi, H. (2002) · Pathology - Research and Practice · doi:10.1078/0344-0338-00337 · Cited by 24
Venugopalan, M., Wood, T. F., Wilczynski, S. P., Sen, S., Peters, J., Gary, C., Evans, G. A., & Srivatsan, E. S. (1998) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(97)00461-5 · Cited by 24
Alterations of the P16 gene in uterine cervical carcinoma from Indian patients
(bhar), A. T., Banerjee, S., Roy, A. K., Roychowdhury, S., & Panda, C. K. (2003) · International Journal of Gynecological Cancer · doi:10.1046/j.1525-1438.2003.13330.x · Cited by 24
Alteration of G2 Cell Cycle Regulators Occurs during Carcinogenesis of the Endometrium
Tsuda, H., Hashiguchi, Y., Inoue, T., & Yamamoto, K. (2003) · Oncology · doi:10.1159/000072342 · Cited by 24
Spathis, A., Aga, E., Alepaki, M., Chranioti, A., Meristoudis, C., Panayiotides, I. G., Kassanos, D., & Karakitsos, P. (2011) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1155/2011/927861 · Cited by 24
Park, J. H., Lee, C., Suh, J. H., Chae, J. Y., & Moon, K. C. (2013) · Human Pathology · doi:10.1016/j.humpath.2013.03.009 · Cited by 24
Prognostic significance of the allelic loss of the BRCA1 gene in colorectal cancer
García, J., Rodríguez, R., Domínguez, G., Silva, J., Provencio, M., Silva, J., Colmenarejo, A., Millán, I., Muñoz, C., Salas, C., et al. (2003) · Gut · doi:10.1136/gut.52.12.1756 · Cited by 24
Prognostic value of INPP4B protein immunohistochemistry in ovarian cancer.
Salmena, L., Shaw, P. H., Fans, I., McLaughlin, Rosen, B. P., Risch, H. A., Mitchell, C. A., Sun, P., Narod, S. A., & Kotsopoulos, J. (2015) · PubMed · Cited by 23
Lu, D., Nounou, R., Beran, M., Estey, E., Manshouri, T., Kantarjian, H., Keating, M. J., & Albitar, M. (2003) · Cancer · doi:10.1002/cncr.11037 · Cited by 23
Rajasekaran, N., Jung, H. S., Bae, S. H., Chelakkot, C., Hong, S., Choi, J., Yim, D., Oh, Y., Choi, Y., & Shin, Y. K. (2017) · Neoplasia · doi:10.1016/j.neo.2017.07.005 · Cited by 23
Self-citationKapitanović, S., Čaćev, T., Radošević, S., Spaventi, Š., Spaventi, R., & Pavelić, K. (2004) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2004.06.001 · Cited by 22
Localization‐specific LKB1 loss in head and neck squamous cell carcinoma metastasis
Kline, E. R., Müller, S., Pan, L., Tighiouart, M., Chen, Z. (., & Marcus, A. I. (2010) · Head & Neck · doi:10.1002/hed.21638 · Cited by 22
Somatic mutations in the neurofibromatosis 1 gene in gliomas and primitive neuroectodermal tumours.
Thiel, G., Marczinek, K., Neumann, R., Witköwski, R., Marchuk, D. A., & Nürnberg, P. (1995) · PubMed · Cited by 21
Wu, L.-B., Kushima, R., Borchard, F., et al. (1998) · Pathology - Research and Practice · doi:10.1016/s0344-0338(98)80031-9 · Cited by 20
Decreased expression of DCC mRNA in gastric and colorectal cancer
Kataoka, M., Okabayashi, T., & Orita, K. (1995) · Surgery Today · doi:10.1007/bf00311682 · Cited by 20
TP53 R72P polymorphism modulates DNA methylation in hepatocellular carcinoma
Rebbani, K., Marchio, A., Ezzikouri, S., Afifi, R., Kandil, M., Bahri, O., Triki, H., Feydi, A. E. E., Dejean, A., Benjelloun, S., et al. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0340-2 · Cited by 20
Reduced expression of hMSH2 and hMLH1 and risk of prostate cancer: A case‐control study
Strom, S. S., Spitz, M. R., Yamamura, Y., Babaian, R. J., Scardino, P. T., & Wei, Q. (2001) · The Prostate · doi:10.1002/pros.1071 · Cited by 20
PTEN deletion is rare but often homogeneous in gastric cancer
Mina, S., Bohn, B. A., Simon, R., Krohn, A., Reeh, M., Arnold, D., Bokemeyer, C., Sauter, G., Izbicki, J. R., Marx, A. H., et al. (2012) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2011-200525 · Cited by 20
Harada, H., Miyamoto, K., Yamashita, Y., Nakano, K., Taniyama, K., Miyata, Y., Ohdan, H., & Okada, M. (2013) · Cancer · doi:10.1002/cncr.27754 · Cited by 19
Toda, T., Oku, H., Khaskhely, N. M., Moromizato, H., Ono, I., & Murata, T. (2001) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(00)00400-3 · Cited by 19
Retinoblastoma (RB1) pocket domain mutations and promoter hyper-methylation in head and neck cancer
Sabir, M., Baig, R. M., Ali, K., Mahjabeen, I., Saeed, M., & Kayani, M. A. (2014) · Cellular Oncology · doi:10.1007/s13402-014-0173-9 · Cited by 19
Rubio‐del‐Campo, A., Sánchez, A. S. S., Sánchez‐Sánchez, F., Bachs, J. M. G., Donate‐Moreno, M. J., Pastor‐Navarro, H., Carrión‐López, P., & Escribano, J. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.07581.x · Cited by 19
Ribeiro‐Silva, A., Moutinho, M. A. K., de Moura, H. B., do Vale, F. R., & Zucoloto, S. (2006) · PubMed · doi:10.14670/hh-21.373 · Cited by 18
Tumor profiling of gastric and esophageal carcinoma reveal different treatment options
Miura, J. T., Xiu, J., Thomas, J. P., George, B., Carron, B. R., Tsai, S., Johnston, F. M., Turaga, K. K., & Gamblin, T. C. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1026479 · Cited by 18
Alterations of the retinoblastoma gene in metastatic breast cancer
Berge, E. O., Knappskog, S., Lillehaug, J. R., & Lønning, P. E. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9375-y · Cited by 18
Molecular analysis of the TSC1 gene in adenocarcinoma of the lung
Takamochi, K., Ogura, T., Yokose, T., Ochiai, A., Nagai, K., Nishiwaki, Y., Suzuki, K., & エスミ, ヒ. (2004) · Lung Cancer · doi:10.1016/j.lungcan.2004.05.001 · Cited by 18
Mutalib, N. A., Syafruddin, S. E., Zain, R. R. M., Dali, A. Z. H. M., Yunos, R. I. M., Saidin, S., Jamal, R., & Mokhtar, N. M. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-805 · Cited by 17
Clinical significance and role of LKB1 in gastric cancer
Jiang, S., Chen, R., Yu, J., Li, N., Ke, R., Luo, L., Zou, J., Zhang, J., Zhang, K.-H., Lü, N., et al. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4508 · Cited by 17
Wagenius, M., Borg, Å., Johansson, L., Giwercman, A., & Ola Bratt, A. (2006) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/00365590500368518 · Cited by 17
Iyengar, T., Ng, S.-W., Lau, C. C., Welch, W. R., Bell, D. A., Berkowitz, R. S., & Mok, S. C. (1999) · Oncogene · doi:10.1038/sj.onc.1202294 · Cited by 17
Herath, N. I., Kew, M. C., Walsh, M. D., Young, J. P., Powell, L. W., Leggett, B., & Macdonald, G. A. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2002.02704.x · Cited by 16
Muñoz-Antonia, T., Torrellas-Ruiz, M., Clavell, J., Mathews, L. A., Muro‐Cacho, C., & Baez, A. C. (2009) · International Journal of Otolaryngology · doi:10.1155/2009/848695 · Cited by 16
Okada, S., Tokunaga, E., Kitao, H., Akiyoshi, S., Yamashita, N., Saeki, H., Oki, E., Morita, M., Kakeji, Y., & Maehara, Y. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-2166-5 · Cited by 15
Kozłowski, L., Filipowski, T., Rucińska, M., Pepiński, W., Janica, J. R., Skawrońska, M., Poznański, J., & Wojtukiewicz, M. Z. (2006) · PubMed · Cited by 15
Wnt Signaling Proteins Associate with the Nuclear Pore Complex: Implications for Cancer
Sharma, M., Johnson, M., Brocardo, M. G., Jamieson, C., & Henderson, B. R. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-8032-8_16 · Cited by 14
Genetic changes of the E-cadherin and APC tumour suppressor genes in clear cell renal cell carcinoma
Pećina‐Šlaus, N., Gall‐Tros̆elj, K., Šlaus, M., Radić, K., Nikuševa-Martić, T., & Pavelić, K. (2004) · Pathology · doi:10.1080/00313020410001671984 · Cited by 13
LKB1 mutations and their correlation with LKB1 and Rheb expression in bladder cancer
Tigli, H., Seven, D., Tunç, M., Şanlı, Ö., Başaran, Ş., Ulutin, T., & Buyru, N. (2012) · Molecular Carcinogenesis · doi:10.1002/mc.21902 · Cited by 13
PTCH gene expression as a potential marker for esophageal squamous cell carcinoma.
Ishiyama, A., Hibi, K., Koike, M., Fujiwara, M., Kodera, Y., Ito, K., & Nakao, A. (2006) · PubMed · Cited by 13
Zhang, S., 遠藤, 純., Saito, T., Kouno, M., Kuroiwa, T., Washiyama, K., & Kumanishi, T. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00003.x · Cited by 12
Immunohistochemical Expression of Retinoblastoma Protein and p16 in Renal Cell Carcinoma
Maruschke, M., Thur, S., Kundt, G., Nizze, H., & Hakenberg, O. W. (2010) · Urologia Internationalis · doi:10.1159/000320510 · Cited by 12
Wang, C., Wang, X., Liu, H.-B., & Zhou, Z. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.1.355 · Cited by 12
Jin, W., Xu, X., Yang, T., et al. (2000) · PubMed · Cited by 12
Wu, D., Chen, X., Xu, Y., Wang, H., Yu, G., Jiang, L., Hong, Q., & Duan, S. (2017) · Oncology Letters · doi:10.3892/ol.2017.5759 · Cited by 12
Molecular analysis of the retinoblastoma (RB1) gene in acute myeloid leukemia patients
de Melo, M. B., Costa, F. F., Saad, S. T. O., Lorand-Metze, I. G. H., Bordin, S. A., & Ahmad, N. N. (1998) · Leukemia Research · doi:10.1016/s0145-2126(98)00047-2 · Cited by 11
Okon, I. S., Coughlan, K. A., & Zou, M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.500934 · Cited by 11
Predominant Ashkenazi BRCA1/2 Mutations in Families with Pancreatic Cancer
Dagan, E. (2008) · Genetic Testing · doi:10.1089/gte.2007.0101 · Cited by 10
Hasanpour, M., Galehdari, H., Masjedizadeh, A., & Ajami, N. (2014) · Europe PMC (PubMed Central) · Cited by 10
Sp, W., Hj, Z., Xp, C., Ren, G. Y., Xx, R., Zhang, Y., Rl, Z., & Chen, J. (2007) · PubMed · Cited by 10
Huang, J., Chen, H.-W., Wei, Q., Zhang, Z., Zhong, Z., & Xu, Y. (2017) · Oncology Letters · doi:10.3892/ol.2017.5631 · Cited by 10
p14 expression differences in ovarian benign, borderline and malignant epithelial tumors
Cabral, V. D., Cerski, M. R., Brito, I. T. S., & Kliemann, L. M. (2016) · Journal of Ovarian Research · doi:10.1186/s13048-016-0275-2 · Cited by 9
Nuclear tumor suppressors in space and time
Barbie, D. A., Conlan, L. A., & Kennedy, B. K. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.05.005 · Cited by 8
Mutation analysis of RASK and the ‘FLR exon’ of NF1 in sporadic ovarian carcinoma
Foulkes, W. D., Englefield, P., & Campbell, I. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90432-4 · Cited by 8
Upfront molecular testing in patients with advanced gastro-esophageal cancer: Is it time yet?
Mikhail, S., Ciombor, K. K., Noonan, A. M., Wu, C. S.-Y., Goldberg, R. M., Zhao, W., Wei, L., Mathey, K., Yereb, M., Timmers, C. D., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4247 · Cited by 7
Self-citationRare Alteration of Genomic Structure or Expression of the DPC4 Gene in Myelogenous Leukemias
Kaneko, H., Horiike, S., Sasai, Y., Iwai, T., Nakao, M., Yokota, S., Taniwaki, M., Kashima, K., & Misawa, S. (1998) · Acta Haematologica · doi:10.1159/000040837 · Cited by 7
p53 and DPC4 alterations in the bile of patients with pancreatic carcinoma
Pantalone, D., Pelo, E., Minuti, B., Giotti, I., Mazza, E., Falchini, M., Neri, B., Nesi, G., Girardi, L. R., Pulli, R., et al. (2004) · Journal of Surgical Oncology · doi:10.1002/jso.20151 · Cited by 6
Mabuchi, Y., Yamoto, M., Minami, S., & Umesaki, N. (2006) · Oncology Reports · doi:10.3892/or.15.2.291 · Cited by 6
Fu, Q., Yao, G.-Y., Tang, X., Chen, L., & Zheng, Z. (2007) · PubMed · Cited by 6
Mutation analysis of the checkpoint kinase 2 gene in colorectal cancer cell lines
Liu, W., Zhong, B., Yang-de, Z., & Choi, G. (2007) · Chinese Medical Journal · doi:10.1097/00029330-200712010-00010 · Cited by 5
[Studies of TGF-beta/Smads expression in lung cancer].
Shen, J., Yan, C., Liu, Y., Yan, X., Zhang, X., Jin, Y., Zhang, K., Zhan-fa, S., Zhang, G., Li, P., et al. (2003) · Journal of genetics and genomics/Journal of Genetics and Genomics · Cited by 4
Expression of the cell cycle regulators p14ARF and p16INK4a in chronic myeloid leukemia
Cividin, M., Ayrault, O., Sorel, N., Seité, P., Brizard, F., Blanchet, O., Mahon, F., Guilhot, F., Larsen, C. J., Chomel, J., et al. (2006) · Leukemia Research · doi:10.1016/j.leukres.2006.02.002 · Cited by 4
Low frequency of NF1 gene mutations in malignant gliomas
Finocchiaro, G., Tenan, M., Colombo, B. M., Cajola, L., Broggi, G., & Pollo, B. (1993) · European Journal of Cancer · doi:10.1016/s0959-8049(05)80329-6 · Cited by 2
(1992) · PubMed
Cited by
Turner, M. C., Andersen, Z. J., Baccarelli, A., Diver, W. R., Gapstur, S. M., Pope, C. A., Prada, D., Samet, J., Thurston, G., & Cohen, A. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21632 · Cited by 844
Regulating tumor suppressor genes: post-translational modifications
Chen, L., Liu, S., & Tao, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0196-9 · Cited by 449
RosettaDDGPrediction for high‐throughput mutational scans: From stability to binding
(2022) · doi:10.1002/pro.4527 · Cited by 90
Ansari, M. A., Thiruvengadam, M., Venkidasamy, B., Alomary, M. N., Salawi, A., Chung, I.-M., Shariati, M. A., & Rebezov, M. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.04.005 · Cited by 63
Zhong, G., Zhao, Y., Zhuang, D., Chung, W. K., & Shen, Y. (2025) · Nature Communications · doi:10.1038/s41467-025-62318-4 · Cited by 15
Metadata
- Authors
- Wang, L.-H., Wu, C.-F., Rajasekaran, N., & Shin, Y. K.
- Venue
- Cellular Physiology and Biochemistry
- Publisher
- S. Karger AG
- Published
- 2018
- Volume
- 51
- Issue
- 6
- Pages
- 2647-2693
- ISSN
- 1015-8987 (ISSN-L)
- 1421-9778
- OpenAlex
- W2903826068
- Cited by
- 334
- References
- 481
- FWCI
- 9.35
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.